Setting up the KWM International Center is a significant strategic deployment for the firm.
King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating...
Analysis of the 2018-19 Australian Federal Budget: significant reforms for corporates, small business and personal tax.
King & Wood Mallesons (KWM) was the biggest winner with 12 awards at the Thomson Reuters ALB China Law Awards 2018 held in Beijing.
We explore how international arbitration has adapted and will continue to adapt in 2018 to global challenges and opportunities.
Stay Focused on the Policies of Hainan's Pharmaceutical and Healthcare Industry.
King & Wood Mallesons (KWM) acted as the legal counsel to Ant Financial and Ant International for both the RMB tranche and the USD tranche of this project, advising Ant Financial on a wide range of...
In this project, KWM acted for FII as the PRC and Hong Kong SAR counsel, and advised on the restructuring, implementing, reforming and various aspects of the issuance and listing.
King & Wood Mallesons’ cross-border team advised Weichai Power ("Weichai") one of China’s leading automobile and equipment manufacturing companies.